<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04304287</url>
  </required_header>
  <id_info>
    <org_study_id>Orthopedia/autotransfusion</org_study_id>
    <nct_id>NCT04304287</nct_id>
  </id_info>
  <brief_title>The Benefit of Autologous Blood Transfusion in Total Hip Arthroplasty</brief_title>
  <official_title>The Benefit of Autologous Blood Transfusion in Total Hip Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinical Hospital Centre Zagreb</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Clinical Hospital Centre Zagreb</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators studied the benefit of preoperative autologous blood donation in
      participants who undergo total hip arthroplasty. Study is made as a prospective and
      randomized.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Total hip arthroplasty is procedure followed with large perioperative and postoperative blood
      loss. In order to avoid the application of large amounts of allogeneic blood, preoperative
      autologous blood donation as a tipe of autologous transfusion have been developed.

      In this study, the investigators studied the benefit of preoperative autologous blood
      donation in participants who undergo total hip arthroplasty. Study is made as a prospective
      and randomized.

      Participants were divided into three groups: the first group donated one dose of autologous
      blood 14 days preoperatively, the second group donated one dose of autologous blood 72 hours
      preoperatively and a third group was not donated autologous blood.

      The blood parameters, hemodynamic stability, bleeding, the need for application of autologous
      or homologous blood and length of hospital stay were compared.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 16, 2011</start_date>
  <completion_date type="Actual">June 15, 2015</completion_date>
  <primary_completion_date type="Actual">June 15, 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient red blood cells value</measure>
    <time_frame>6 days</time_frame>
    <description>analysis of blood sample day before surgery, 3 hours after surgery, on first, second, fifth postoperative day and on sixth postoperative day</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Need for autologous blood transfusion</measure>
    <time_frame>6 days</time_frame>
    <description>Based on blood count and hemodynamic stability</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Need for homologous blood transfusion</measure>
    <time_frame>6 days</time_frame>
    <description>Based on blood count and hemodynamic stability</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient hemoglobin value</measure>
    <time_frame>6 days</time_frame>
    <description>analysis of blood sample day before surgery, 3 hours after surgery, on first, second, fifth postoperative day and on sixth postoperative day</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient hematocrit value</measure>
    <time_frame>6 days</time_frame>
    <description>analysis of blood sample day before surgery, 3 hours after surgery, on first, second, fifth postoperative day and on sixth postoperative day</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>6 days</time_frame>
    <description>measure of length of hospital stay</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Transfusion</condition>
  <condition>Hip Arthroplasty</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Preoperative blood donations 14 day before total hip replacement procedure Donation of one dose of autologous blood 14 day before total hip replacement procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active comparator</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Preoperative blood donation 72 hours before total hip replacement procedure Donation of one dose of autologous blood 72 hours before total hip replacement procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Other</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Without preoperative blood donation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Preoperative autologous blood donation, 14 days before surgery</intervention_name>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Preoperative autologous blood donation, 72 hours before surgery</intervention_name>
    <arm_group_label>Active comparator</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Without preoperative blood donation</intervention_name>
    <arm_group_label>Other</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  subject older than 18 years

          -  subject has primary coxarthrosis

          -  subject has indication for total hip replacement

        Exclusion Criteria:

          -  subject has secondary coxarthrosis

          -  subject has need for revision endoprosthesis

          -  history of autoimmune, malignancy or coagulation disorder

          -  history of myocardial infarct or cerebrovascular insult in last 6 months

          -  history of angina pectoris and unregulated hypertension

          -  history of renal or liver failure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Domagoj Delimar, MD</last_name>
    <role>Study Director</role>
    <affiliation>Clinical Hospital Centre Zagreb</affiliation>
  </overall_official>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 27, 2020</study_first_submitted>
  <study_first_submitted_qc>March 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 11, 2020</study_first_posted>
  <last_update_submitted>March 18, 2020</last_update_submitted>
  <last_update_submitted_qc>March 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Clinical Hospital Centre Zagreb</investigator_affiliation>
    <investigator_full_name>Zrinka Oreskovic</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>total hip arthroplasty</keyword>
  <keyword>autologous blood donation</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

